James Mond
Plus aucun poste en cours
Profil
James Mond served as the Chief Medical Officer at Phase III Medical, Inc. before becoming the Executive VP, Chief Scientific & Medical Officer at ADMA Biologics, Inc. where he worked from 2012 to 2021.
Prior to that, he was the Chief Scientific Officer at Biosynexus, Inc. from 1999 to 2011.
He also worked as a Professor at the Uniformed Services University of the Health Sciences.
Dr. Mond holds a doctorate degree from the New York University School of Medicine.
Anciens postes connus de James Mond
| Sociétés | Poste | Fin |
|---|---|---|
| ADMA BIOLOGICS, INC. | Directeur Technique/Scientifique/R&D | 08/06/2021 |
Biosynexus, Inc.
 Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Biosynexus, Inc. develops and markets pharmaceutical products. The company is headquartered in Rockville, MD. | Directeur Technique/Scientifique/R&D | 01/06/2011 |
| Phase III Medical, Inc. | Directeur Technique/Scientifique/R&D | - |
| Uniformed Services University of the Health Sciences | Corporate Officer/Principal | - |
Formation de James Mond
| New York University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ADMA BIOLOGICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Biosynexus, Inc.
Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Biosynexus, Inc. develops and markets pharmaceutical products. The company is headquartered in Rockville, MD. | Health Technology |
| Phase III Medical, Inc. | Finance |
